Short-term efficacy of vedolizumab in patients with inflammatory bowel disease in real-life settings in Bosnia and Herzegovina

Inflammatory bowel disease (IBD), encompassing Crohn's disease (CD) and ulcerative colitis (UC), necessitates effective management strategies. This study aims to evaluate the real-world efficacy of vedolizumab, a newer biological therapy, in treating IBD in Bosnia and Herzegovina. A retrospect...

وصف كامل

التفاصيل البيبلوغرافية

الحاوية / القاعدة:	Biomolecules & Biomedicine
المؤلفون الرئيسيون:	Nermin Salkić, Mirela Bašić Denjagić, Nađa Zubčević, Renata Tamburić, Azra Husić Selimović, Emil Babić, Milenko Bevanda, Aida Saray, Predrag Jovanović, Zoran Tošić, Aleksandar Dobrovoljski, Tatjana Barać
التنسيق:	مقال
اللغة:	الإنجليزية
منشور في:	Association of Basic Medical Sciences of Federation of Bosnia and Herzegovina 2024-04-01
الموضوعات:	Inflammatory bowel disease (IBD) vedolizumab Crohn's disease (CD) ulcerative colitis (UC) real-world efficacy
الوصول للمادة أونلاين:	https://www.bjbms.org/ojs/index.php/bjbms/article/view/10433